Skip to main content

WORKING AT
THE EDGE OF  
IMPOSSIBLE 

TO HELP DELIVER
BREAKTHROUGH
CELL & GENE
THERAPIES

 

WELCOME TO OXGENE

OXGENE is the innovation arm of WuXi Advanced Therapies, providing expert design and engineering services for viral vector optimisation and cell line development, seamlessly integrated with WuXi Advanced Therapies’ GMP manufacturing and testing platforms.

Together our technologies, automation platforms and service solutions accelerate time to market for cell and gene therapies, with proprietary manufacturing platforms ensuring high titres, high levels of quality assurance and full regulatory compliance.

Ultimately, our complete end-to-end solutions support pioneering companies to deliver breakthrough cell and gene therapies to the patients who need them in the fastest possible time.

By combining WuXi ATU's world class cell and gene therapy CTDMO platform with OXGENE's innovative capabilities, we will be able to provide transformative solutions for our customers.

DAVID CHANG, CEO, WUXI ADVANCED THERAPIES

 

Dr Ryan Cawood

Chief Scientific Officer,
OXGENE and WuXi ATU

OUR MISSION IS TO
ACCELERATE SUCCESS

TECHNOLOGY AT THE
EDGE OF IMPOSSIBLE

Based in Oxford, UK, we help cell and gene therapy pioneers accelerate development of their breakthrough therapeutics.
 

Leadership

Careers

Then and Now: Interview with Ryan Cawood

Our Awards

Our pioneering spirit drives our success. We're honoured to be recognised in the following awards.

BE FIRST in the race to deliver
breakthrough Cell & Gene Therapies

Are you ready for GMP Manufacture?

WuXi Advanced Therapies is a global Contract Testing, Development
and Manufacturing Organization (CTDMO) dedicated to accelerating
progress and time to market for cell and gene therapies.

×